FDA Investigates Brain Infection-Gilenya Case

The FDA is continuing to investigate a possible link between the multiple sclerosis drug Gilenya (fingolimod) and a case of a rare brain infection in a European patient.
Source: WebMD Health - Category: Consumer Health News Source Type: news